Advertisement

International Journal of Behavioral Medicine

, Volume 25, Issue 2, pp 252–258 | Cite as

Predictors of Daily Pain Medication Use in Individuals with Recurrent Back Pain

  • John A. Sturgeon
  • Jennifer M. Hah
  • Yasamin Sharifzadeh
  • Stephanie K. Middleton
  • Thomas Rico
  • Kevin A. Johnson
  • Sean C. Mackey
Article

Abstract

Purpose

A key component to chronic pain management regimens is the use of analgesic medications. Psychological factors, such as mood states, may also affect the use of pain medications for individuals with chronic pain, but few observational studies have examined how these factors may predict pain medication use at the daily level.

Methods

Daily assessments from 104 individuals with back pain were used to examine fluctuations in daily pain intensity, mood, sleep quality, and physical activity as predictors of the likelihood of pain medication (opioid and non-opioid) use and levels of medication use on the same day.

Results

Pain intensity and mood ratings significantly predicted whether participants used pain medication on the same day, while only pain intensity predicted whether participants used more medication than usual. Further, current opioid users were more likely to increase the amount of their medication use on days of higher pain.

Discussion

This article identifies fluctuations in daily pain intensity and mood as salient predictors of daily pain medication use in individuals with recurrent back pain. The current study is among the first to highlight both pain and mood states as predictors of daily pain medication use in individuals with back pain, though future studies may expand on these findings through the use of higher-resolution daily medication use variables.

Keywords

Daily diaries Pain intensity Mood Opioid medications Medication use 

Notes

Funding

This study received funding from the National Institute on Drug Abuse (K23DA031808, 3T32DA035165-02S1, K24 DA029262) and the Redlich Pain Endowment.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Setnik B, Roland CL, Sommerville KW, et al. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res. 2015;8:361–73.  https://doi.org/10.2147/JPR.S82396.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manag. 2004;27(5):440–59.  https://doi.org/10.1016/j.jpainsymman. 2003.10.009.CrossRefGoogle Scholar
  3. 3.
    Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6(1):46.  https://doi.org/10.1186/1472-6963-6-46.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Merrill JO, Von Koff M, Banta-Green CJ, et al. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012;34(6):581–7.  https://doi.org/10.1016/j.genhosppsych.2012.06.018.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125(1–2):172–9.  https://doi.org/10.1016/j.pain.2006.06.009.CrossRefPubMedGoogle Scholar
  6. 6.
    Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend. 2013;127(1–3):193–9.  https://doi.org/10.1016/j.drugalcdep.2012.06.032.CrossRefPubMedGoogle Scholar
  7. 7.
    Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012;10(4):304–11.  https://doi.org/10.1370/afm.1371.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Raymond-Shaw I, Lavigne G, Mayer P, Choiniere M. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain free young adults: a preliminary study. Sleep. 2005;28(6):677–82.CrossRefGoogle Scholar
  9. 9.
    Arteta J, Cobos B, Hu YQ, Jordan K, Howard K. Evaluation of how depression and anxiety mediate the relationship between pain catastrophizing and prescription opioid misuse in a chronic pain population. Pain Med. 2016;17(2):295–303.  https://doi.org/10.1111/pme.12886.PubMedGoogle Scholar
  10. 10.
    Martel MO, Wasan AD, Jamison RN, Edwards RR. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend. 2013;132(1–2):335–41.  https://doi.org/10.1016/j.drugalcdep.2013.02.034.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ferrari R, Duse G, Capraro M, Visentin M. Risk assessment of opioid misuse in Italian patients with chronic noncancer pain. Pain Res Treat. 2014;2014:584986.  https://doi.org/10.1155/2014/584986.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati B. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag. 2007;5:8.Google Scholar
  13. 13.
    Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30(3):185–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Broderick JE, Schwartz JE, Schneider S, Stone AA. Can end-of-day reports replace momentary assessment of pain and fatigue? J Pain. 2009;10(3):274–81.CrossRefPubMedGoogle Scholar
  15. 15.
    Broderick JE, Schwartz JE, Vikingstad G, Pribbernow M, Grossman S, Stone AA. The accuracy of pain and fatigue items across different reporting periods. Pain. 2008;139(1):146–57.  https://doi.org/10.1016/j.pain.2008.03.024.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Martel MO, Finan PH, McHugh RK, et al. Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug Alcohol Depend. 2016;162:130–6.  https://doi.org/10.1016/j.drugalcdep.2016.02.047.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.  https://doi.org/10.1016/j.jbi.2008.08.010.CrossRefPubMedGoogle Scholar
  18. 18.
    Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17(1):45–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Ahearn EP. The use of visual analog scales in mood disorders: a critical review. J Psychiatr Res. 1997;31(5):569–79.  https://doi.org/10.1016/S0022-3956(97)00029-0.CrossRefPubMedGoogle Scholar
  20. 20.
    Muthén LK, Muthén BO. Mplus: statistical analysis with latent variables: user’s guide; [Version 5]: Muthén & Muthén. 2007.Google Scholar
  21. 21.
    Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse. 1992;18(2):121–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Dyer KR, White JM, Foster DJ, Bochner F, Menelaou A, Somogyi AA. The relationship between mood state and plasma methadone concentration in maintenance patients. J Clin Psychopharmacol. 2001;21(1):78–84.CrossRefPubMedGoogle Scholar
  23. 23.
    Galynker II, Eisenberg D, Matochik JA, et al. Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend. 2007;90(2–3):166–74.  https://doi.org/10.1016/j.drugalcdep.2007.03.015.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Savvas SM, Somogyi AA, White JM. The effect of methadone on emotional reactivity. Addiction. 2012;107(2):388–92.  https://doi.org/10.1111/j.1360-0443.2011.03634.x.CrossRefPubMedGoogle Scholar
  25. 25.
    Filliol D, Ghozland S, Chluba J, et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet. 2000;25(2):195–200.  https://doi.org/10.1038/76061.CrossRefPubMedGoogle Scholar
  26. 26.
    Kosten TR, Morgan C, Kosten TA. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abus Treat. 1990;7(1):51–4.CrossRefGoogle Scholar
  27. 27.
    Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 2002;72(2):143–52.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2017

Authors and Affiliations

  1. 1.Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain MedicineStanford University School of Medicine, Stanford Systems Neuroscience and Pain LaboratoryPalo AltoUSA

Personalised recommendations